Oliyai; Reza
Patent Applications and Registrations
Patent applications and USPTO patent grants for Oliyai; Reza.The latest application filed is for "combination formulation of two antiviral compounds".
Company Profile
6.27.40
- Oliyai; Reza - Burlingame CA
- Oliyai; Reza - Foster City CA
- Oliyai; Reza - San Carlos CA
- Oliyai; Reza - San Carios CA
- Oliyai; Reza - San Ramon CA
Patent Activity
| Patent | Date |
|---|---|
| Combination Formulation Of Two Antiviral Compounds App 20220072021 - Gorman; Eric ; et al. | 2022-03-10 |
| Combination formulation of two antiviral compounds Grant 11,116,783 - Gorman , et al. September 14, 2 | 2021-09-14 |
| Combination Formulation Of Two Antiviral Compounds App 20210000854 - Gorman; Eric ; et al. | 2021-01-07 |
| Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate Grant 10,857,102 - Oliyai , et al. December 8, 2 | 2020-12-08 |
| Combination Formulation Of Two Antiviral Compounds App 20200188419 - Chal; Ben ; et al. | 2020-06-18 |
| Combination Formulation Of Two Antiviral Compounds App 20190240246 - Gorman; Eric ; et al. | 2019-08-08 |
| Combination Formulation Of Two Antiviral Compounds App 20190111068 - Chal; Ben ; et al. | 2019-04-18 |
| Combination formulation of two antiviral compounds Grant 10,086,011 - Gorman , et al. October 2, 2 | 2018-10-02 |
| Combination formulation of two antiviral compounds Grant 10,039,779 - Chal , et al. August 7, 2 | 2018-08-07 |
| Combination Formulation Of Two Antiviral Compounds App 20180021362 - Gorman; Eric ; et al. | 2018-01-25 |
| Compositions And Methods For Treating Hepatitis C Virus App 20170348342 - Berrey; Miriam Michelle ; et al. | 2017-12-07 |
| Compositions and Methods for Combination Antiviral Therapy App 20170273994 - Dahl; Terrence C. ; et al. | 2017-09-28 |
| Combination formulation of two antiviral compounds Grant 9,757,406 - Gorman , et al. September 12, 2 | 2017-09-12 |
| Compositions and methods for combination antiviral therapy Grant 9,744,181 - Dahl , et al. August 29, 2 | 2017-08-29 |
| Compositions and Methods for Combination Antiviral Therapy App 20170232019 - Dahl; Terrence C. ; et al. | 2017-08-17 |
| Combination Formulation Of Two Antiviral Compounds App 20170202865 - Chal; Ben ; et al. | 2017-07-20 |
| Combination Formulation Of Two Antiviral Compounds App 20170095499 - Gorman; Eric ; et al. | 2017-04-06 |
| Unitary Pharmaceutical Dosage Form App 20170079999 - DAHL; Terrence C. ; et al. | 2017-03-23 |
| Compositions and methods for treating hepatitis C virus Grant 9,549,941 - Cleary , et al. January 24, 2 | 2017-01-24 |
| Unitary pharmaceutical dosage form Grant 9,545,414 - Dahl , et al. January 17, 2 | 2017-01-17 |
| Compositions and methods for combination antiviral therapy Grant 9,457,036 - Dahl , et al. October 4, 2 | 2016-10-04 |
| Combination Formulation Of Two Antiviral Compounds App 20160120892 - Chal; Ben ; et al. | 2016-05-05 |
| Tablets For Combination Therapy App 20150150810 - OLIYAI; Reza ; et al. | 2015-06-04 |
| Compositions And Methods For Treating Hepatitis C Virus App 20150150896 - Cleary; Darryl G. ; et al. | 2015-06-04 |
| Unitary pharmaceutical dosage form Grant 9,018,192 - Dahl , et al. April 28, 2 | 2015-04-28 |
| Compositions And Methods For Combination Antiviral Therapy App 20150111855 - Dahl; Terrence C. ; et al. | 2015-04-23 |
| Compositions And Methods For Combination Antiviral Therapy App 20150111856 - Dahl; Terrence C. ; et al. | 2015-04-23 |
| Solid Dispersion Formulation Of An Antiviral Compound App 20150064252 - Gorman; Eric ; et al. | 2015-03-05 |
| Combination Formulation Of Two Antiviral Compounds App 20150064253 - Gorman; Eric ; et al. | 2015-03-05 |
| Method And Composition For Pharmaceutical Product App 20140370102 - Dahl; Terrence C. ; et al. | 2014-12-18 |
| Compositions and methods for treating hepatitis C virus Grant 8,889,159 - Cleary , et al. November 18, 2 | 2014-11-18 |
| Method and composition for pharmaceutical product Grant 8,871,271 - Dahl , et al. October 28, 2 | 2014-10-28 |
| Combination Formulation Of Two Antiviral Compounds App 20140212491 - Chal; Ben ; et al. | 2014-07-31 |
| Solid Dispersion Formulation Of An Antiviral Compound App 20140212487 - Mogalian; Erik ; et al. | 2014-07-31 |
| Compositions and methods for combination antiviral therapy Grant 8,716,264 - Dahl , et al. May 6, 2 | 2014-05-06 |
| Method And Composition For Pharmaceutical Product App 20140037732 - Dahl; Terrence C. ; et al. | 2014-02-06 |
| Unitary Pharmaceutical Dosage Form App 20140037724 - Dahl; Terrence C. ; et al. | 2014-02-06 |
| Unitary pharmaceutical dosage form Grant 8,598,185 - Dahl , et al. December 3, 2 | 2013-12-03 |
| Compositions and methods for combination antiviral therapy Grant 8,592,397 - Dahl , et al. November 26, 2 | 2013-11-26 |
| Pyridazine compound and use thereof Grant 8,569,487 - Bondy , et al. October 29, 2 | 2013-10-29 |
| Therapeutic Compositions Comprising Rilpivirine Hcl And Tenofovir Disoproxil Fumarate App 20130243857 - Oliyai; Reza ; et al. | 2013-09-19 |
| Compositions And Methods For Treating Hepatitis C Virus App 20130136776 - Cleary; Darryl G. ; et al. | 2013-05-30 |
| Tablets For Combination Therapy App 20100285122 - Oliyai; Reza ; et al. | 2010-11-11 |
| Pyridazine compound and use thereof Grant 7,754,720 - Bondy , et al. July 13, 2 | 2010-07-13 |
| Novel Pyridazine Compound And Use Thereof App 20100152444 - Bondy; Steven S. ; et al. | 2010-06-17 |
| Novel Pyridazine Compound And Use Thereof App 20100063059 - Bondy; Steven S. ; et al. | 2010-03-11 |
| Use Of Solid Carrier Particles To Improve The Processability Of A Pharmaceutical Agent App 20090324729 - Koziara; Joanna M. ; et al. | 2009-12-31 |
| Compositions And Methods For Combination Antiviral Therapy App 20090143314 - Dahl; Terrence C. ; et al. | 2009-06-04 |
| Compositions And Methods For Combination Antiviral Therapy App 20090036408 - Dahl; Terrence C. ; et al. | 2009-02-05 |
| Novel pyridazine compound and use thereof App 20080199427 - Bondy; Steven S. ; et al. | 2008-08-21 |
| Unitary pharmaceutical dosage form App 20070099902 - Dahl; Terrence C. ; et al. | 2007-05-03 |
| Method and composition for pharmaceutical product App 20070077295 - Dahl; Terrence C. ; et al. | 2007-04-05 |
| Compositions and methods for combination antiviral therapy App 20060246130 - Dahl; Terrence C. ; et al. | 2006-11-02 |
| Compositions and methods for combination antiviral therapy App 20060234982 - Dahl; Terrence C. ; et al. | 2006-10-19 |
| Compositions and methods for combination antiviral therapy App 20040224916 - Dahl, Terrance C. ; et al. | 2004-11-11 |
| Compositions and methods for combination antiviral therapy App 20040224917 - Dahl, Terrance C. ; et al. | 2004-11-11 |
| Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant RE38,333 - Arimilli , et al. November 25, 2 | 2003-11-25 |
| Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 6,069,249 - Arimilli , et al. May 30, 2 | 2000-05-30 |
| Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 6,043,230 - Arimilli , et al. March 28, 2 | 2000-03-28 |
| Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 5,977,089 - Arimilli , et al. November 2, 1 | 1999-11-02 |
| Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability Grant 5,922,695 - Arimilli , et al. July 13, 1 | 1999-07-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 